Partner Content Partner Content IATA's CEIV-Pharma Certification or HSA's GDP Certification? 13th Cold Chain Distribution Conference
Partner Content Partner Content The Power of Partnerships: Meeting Pharmaceutical Logistic E... Partnerships in the Supply Chain
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
